These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 36124816)
1. Perspectives on the use of non-biological pharmacotherapy for adult-onset Still's disease. Di Cola I; Cipriani P; Ruscitti P Expert Opin Pharmacother; 2022 Oct; 23(14):1577-1587. PubMed ID: 36124816 [TBL] [Abstract][Full Text] [Related]
2. Current treatment options and safety considerations when treating adult-onset Still's disease. Cavalli G; Farina N; Campochiaro C; Baldissera E; Dagna L Expert Opin Drug Saf; 2020 Dec; 19(12):1549-1558. PubMed ID: 33078630 [TBL] [Abstract][Full Text] [Related]
3. The administration of methotrexate in patients with Still's disease, "real-life" findings from AIDA Network Still Disease Registry. Ruscitti P; Sota J; Vitale A; Lopalco G; Iannone F; Morrone M; Giardini HAM; D'Agostin MA; Antonelli IPB; Almaghlouth I; Asfina KN; Khalil N; Sfikakis PP; Laskari K; Tektonidou M; Ciccia F; Iacono D; Riccio F; Ragab G; Hussein MA; Govoni M; Ruffilli F; Direskeneli H; Alibaz-Oner F; Giacomelli R; Navarini L; Bartoloni E; Riccucci I; Martín-Nares E; Torres-Ruiz J; Cipriani P; Di Cola I; Hernández-Rodríguez J; Gómez-Caverzaschi V; Dagna L; Tomelleri A; Makowska J; Brzezinska O; Iagnocco A; Bellis E; Caggiano V; Gaggiano C; Tarsia M; Mormile I; Emmi G; Sfriso P; Monti S; Erten Ş; Del Giudice E; Lubrano R; Conti G; Olivieri AN; Lo Gullo A; Tharwat S; Karamanakos A; Gidaro A; Maggio MC; La Torre F; Cardinale F; Ogunjimi B; Maier A; Sebastiani GD; Opris-Belinski D; Frassi M; Viapiana O; Bizzi E; Carubbi F; Fotis L; Tufan A; Kardas RC; Więsik-Szewczyk E; Jahnz-Różyk K; Fabiani C; Frediani B; Balistreri A; Rigante D; Cantarini L Semin Arthritis Rheum; 2023 Oct; 62():152244. PubMed ID: 37517110 [TBL] [Abstract][Full Text] [Related]
4. Adult-onset Still's disease: Advances in the treatment. Castañeda S; Blanco R; González-Gay MA Best Pract Res Clin Rheumatol; 2016 Apr; 30(2):222-238. PubMed ID: 27886796 [TBL] [Abstract][Full Text] [Related]
5. Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies. Efthimiou P; Kontzias A; Hur P; Rodha K; Ramakrishna GS; Nakasato P Semin Arthritis Rheum; 2021 Aug; 51(4):858-874. PubMed ID: 34175791 [TBL] [Abstract][Full Text] [Related]
7. Cardiac involvement in adult-onset Still's disease: Manifestations, treatments and outcomes in a retrospective study of 28 patients. Bodard Q; Langlois V; Guilpain P; Le Quellec A; Vittecoq O; Noel D; Eble V; Josse S; Schmidt J; Aouba A; Levesque H; Le Besnerais M; Benhamou Y J Autoimmun; 2021 Jan; 116():102541. PubMed ID: 32943282 [TBL] [Abstract][Full Text] [Related]
8. A Case of Adult-Onset Still's Disease Treated with Monitoring of Serum Tacrolimus Levels. Ohe M; Bohgaki T Bull Hosp Jt Dis (2013); 2015 Jul; 73(3):213-6. PubMed ID: 26535602 [TBL] [Abstract][Full Text] [Related]
9. Anakinra for the treatment of adult-onset Still's disease. Castañeda S; Atienza-Mateo B; Martín-Varillas JL; Serra López-Matencio JM; González-Gay MA Expert Rev Clin Immunol; 2018 Dec; 14(12):979-992. PubMed ID: 30324816 [TBL] [Abstract][Full Text] [Related]
10. Treatment of refractory adult-onset Still's disease with tocilizumab: report of two cases and review of the literature. Thonhofer R; Hiller M; Just H; Trummer M; Siegel C; Dejaco C Rheumatol Int; 2011 Dec; 31(12):1653-6. PubMed ID: 21240503 [TBL] [Abstract][Full Text] [Related]
11. [The prognosis and treatment of Still's disease in adults]. Holgado S; Casado E; Olivé A; Tena X Med Clin (Barc); 1999 Mar; 112(9):356. PubMed ID: 10220769 [No Abstract] [Full Text] [Related]
12. Management of adult-onset Still's disease: evidence- and consensus-based recommendations by experts. Leavis HL; van Daele PLA; Mulders-Manders C; Michels R; Rutgers A; Legger E; Bijl M; Hak EA; Lam-Tse WK; Bonte-Mineur F; Fretter P; Simon A; van Paassen P; van der Goes MC; Flendrie M; Vercoutere W; van Lieshout AWT; Leek A; Vastert SJ; Tas SW Rheumatology (Oxford); 2024 May; 63(6):1656-1663. PubMed ID: 37669122 [TBL] [Abstract][Full Text] [Related]
14. The latest advances in the use of biological DMARDs to treat Still's disease. Di Cola I; Ruscitti P Expert Opin Biol Ther; 2024; 24(1-2):63-75. PubMed ID: 38284774 [TBL] [Abstract][Full Text] [Related]
15. Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission. Giacomelli R; Caporali R; Ciccia F; Colafrancesco S; Dagna L; Govoni M; Iannone F; Leccese P; Montecucco C; Pappagallo G; Pistone G; Priori R; Ruscitti P; Sfriso P; Cantarini L; Autoimmun Rev; 2023 Dec; 22(12):103400. PubMed ID: 37482365 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still's disease. Franchini S; Dagna L; Salvo F; Aiello P; Baldissera E; Sabbadini MG Arthritis Rheum; 2010 Aug; 62(8):2530-5. PubMed ID: 20506370 [TBL] [Abstract][Full Text] [Related]
18. [Anakinra in refractory adult onset Still's disease]. Vercoutere W; Starmans-Kool M; Peeters RM Ned Tijdschr Geneeskd; 2011; 155(18):A2966. PubMed ID: 21466723 [TBL] [Abstract][Full Text] [Related]
19. A case of refractory adult-onset Still's disease treated with anakinra. Lahiri M; Teng GG Int J Rheum Dis; 2010 Aug; 13(3):e36-41. PubMed ID: 20704609 [TBL] [Abstract][Full Text] [Related]